Microcaps AG, a Swiss-based company, has recently announced that it has successfully raised CHF 9.3M (€9.6M) in a Series A funding round. The funds will be used to enhance the company’s production facilities and continue development efforts for applications beyond fragrances. Microcaps aims to increase its manufacturing capabilities to meet the growing demand for its ethanol-free Perfume Pearls, which offer unmatched scent longevity and intensity.
The support from shareholders, including new private investors and existing shareholders such as Helvetica Capital AG, Zürcher Kantonalbank, and the ETH Foundation, demonstrates their belief in Microcaps’ mission to innovate and lead in the microencapsulation sector.
Founded in 2019 by Dr. Alessandro Ofner and Michael Hagander, Microcaps specialises in advanced microencapsulation solutions. Developed from ETH Zurich’s Complex Material Group, the company’s technology enables the scalable production of precise microcapsules and microparticles based on microfluidics. This technology allows for the encapsulation of active ingredients within microscopic capsules, providing precise control over release rates and enhancing product performance.
Microcaps’ flagship product, Perfume Pearls, offers unmatched scent longevity and intensity. The company’s solutions cater to a variety of industries, including pharmaceuticals, cosmetics, and food technology. With the recent funding secured, Microcaps is poised to expand its production capacity and continue its mission to revolutionize industries with novel encapsulation solutions.
Michael Hagander, co-CEO of Microcaps expressed excitement about the funding round stating that it is a validation of their patented technology and increasing demand for Perfume Pearls.
